← Leaderboards
Barbara J. Caldarone
Psychogenics, Inc.
$943,262
Attributed
$1,829,787
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $670.4K · FY2007–16$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$1,829,787 · 2
By mechanism
R01$1,329,787 · 1
R43$500,000 · 1
Top collaborators
- Bryan L Roth2 shared
- Alan P. Kozikowski1 shared
- Duncan John Wardrop1 shared
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignIn VivoMental DepressionPharmaceutical PreparationsMental DisordersBaseLeadMedicalMetabolicPre-ClinicalMolecular TargetBehavioral AssayAgonistBehaviorNational Institute Of Mental Health (U.S.)AreaAntipsychotic AgentsAntidepressive AgentsAnimal TestingAffinityAddictionBehavioral StudyBehavior AssessmentBehavioral Model
Grant awards (4)
Optimizing Lead 5-HT2c Ligands for Use in the Treatment of Schizophrenia$659,346
R01 · FY2016 · MH
Optimizing Lead 5-HT2c Ligands for Use in the Treatment of Schizophrenia$670,441
R01 · FY2015 · MH
High Throughput Behavioral Testing For Novel Antidepressants$250,000
R43 · FY2008 · MH · contact PI
High Throughput Behavioral Testing For Novel Antidepressants$250,000
R43 · FY2007 · MH · contact PI